Molecule Details
InChIKeyOUKYUETWWIPKQR-UHFFFAOYSA-N
Compound NameSaracatinib
Canonical SMILESCN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1
Clinical Status Clinical Multi-Target
Targets (Human+Pathogen)31
Pfam Stratification Cross-Family
Avg pChEMBL7.21
SourceChEMBL;BindingDB;TTD_MultiTarget
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB11805
Drug NameSaracatinib
CAS Number379231-04-6
Groups investigational
ATC Codes nan
DescriptionSaracatinib has been investigated for the treatment of Cancer, Osteosarcoma, Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer.

Categories: Antineoplastic Agents Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) Cytochrome P-450 Enzyme Inhibitors Dioxoles Enzyme Inhibitors Heterocyclic Compounds, Fused-Ring Tyrosine Kinase Inhibitors
Cross-references: BindingDB: 12255 CHEMBL217092 ChemSpider: 8477917 PDB: H8H PubChem:10302451 PubChem:347828152 Wikipedia: Saracatinib ZINC: ZINC000024811973
Target Activities (31)
Target Gene Organism Category Pfam pChEMBL Type Source
P24941 CDK2 Homo sapiens Human PF00069 9.0 pIC50 TTD_MultiTarget
O43353 RIPK2 Homo sapiens Human PF00619 PF07714 8.7 Kd ChEMBL
P12931 SRC Homo sapiens Human PF07714 PF00017 PF00018 8.6 IC50 ChEMBL;BindingDB
P06239 LCK Homo sapiens Human PF07714 PF00017 PF00018 8.4 IC50 ChEMBL;BindingDB
P07947 YES1 Homo sapiens Human PF07714 PF00017 PF00018 8.4 IC50 ChEMBL;BindingDB
Q04771 ACVR1 Homo sapiens Human PF01064 PF07714 PF08515 8.4 Kd ChEMBL
P21709 EPHA1 Homo sapiens Human PF14575 PF25599 PF01404 PF07699 PF00041 PF07714 PF00536 8.0 Kd ChEMBL
P11274 BCR Homo sapiens Human PF09036 PF00168 PF19057 PF00620 PF00621 7.8 Kd ChEMBL
O00238 BMPR1B Homo sapiens Human PF01064 PF07714 PF08515 7.5 Kd ChEMBL
P00519 ABL1 Homo sapiens Human PF08919 PF07714 PF00017 PF00018 7.5 IC50 ChEMBL;BindingDB
P18505 GABRB1 Homo sapiens Human PF02931 PF02932 7.5 pIC50 TTD_MultiTarget
P36894 BMPR1A Homo sapiens Human PF01064 PF07714 PF08515 7.2 Kd ChEMBL
P00533 EGFR Homo sapiens Human PF00757 PF14843 PF07714 PF01030 PF21314 7.2 IC50 ChEMBL;BindingDB
P42684 ABL2 Homo sapiens Human PF08919 PF07714 PF00017 PF00018 7.0 Kd ChEMBL
P06241 FYN Homo sapiens Human PF07714 PF00017 PF00018 7.0 Kd ChEMBL
P08631 HCK Homo sapiens Human PF07714 PF00017 PF00018 7.0 Kd ChEMBL
O14976 GAK Homo sapiens Human PF00069 PF10409 7.0 Kd ChEMBL
P07948 LYN Homo sapiens Human PF07714 PF00017 PF00018 7.0 Kd ChEMBL
Q99640 PKMYT1 Homo sapiens Human PF00069 6.9 IC50 ChEMBL;BindingDB
P36888 FLT3 Homo sapiens Human PF00047 PF07714 6.8 Kd ChEMBL
P36896 ACVR1B Homo sapiens Human PF01064 PF00069 PF08515 6.8 Kd ChEMBL
P07949 RET Homo sapiens Human PF00028 PF07714 PF17756 PF17812 PF17813 PF22540 6.8 Kd ChEMBL
P36897 TGFBR1 Homo sapiens Human PF01064 PF00069 PF08515 6.7 Kd ChEMBL
P10721 KIT Homo sapiens Human PF00047 PF07714 6.7 IC50 ChEMBL;BindingDB
Q8NI60 COQ8A Homo sapiens Human PF03109 6.6 Kd ChEMBL
P29317 EPHA2 Homo sapiens Human PF14575 PF25599 PF01404 PF00041 PF07714 PF00536 6.3 Kd ChEMBL;BindingDB
Q13882 PTK6 Homo sapiens Human PF07714 PF00017 PF00018 6.2 Kd ChEMBL
P09619 PDGFRB Homo sapiens Human PF00047 PF13927 PF25305 PF07714 6.2 Kd ChEMBL
P41240 CSK Homo sapiens Human PF07714 PF00017 PF00018 6.1 IC50 ChEMBL;BindingDB
P54764 EPHA4 Homo sapiens Human PF14575 PF25599 PF01404 PF00041 PF07714 PF07647 6.0 Kd ChEMBL
P09769 FGR Homo sapiens Human PF07714 PF00017 PF00018 6.0 Kd ChEMBL
DrugBank Target Actions (3)
Target Gene Target Name Action Type
P08684 CYP3A4 Cytochrome P450 3A4 inhibitor enzymes
P00519 ABL1 Tyrosine-protein kinase ABL1 modulator targets
P12931 SRC Proto-oncogene tyrosine-protein kinase Src modulator targets